Abstract
Prostaglandins (PGs) are a group of compounds which have been found to exert numerous and potent physiologic and pharmacologic effects. Their existence was originally reported in seminal fluid about 50 years ago (Kurzrok and Lieb 1930; Goldblatt 1933; von Euler 1934), but the structure of the six primary PGs was only described in the early 1960s (review in Bergström et al. 1968). PGs are found in all mammalian tissues which also appear able to synthesize them. The precursors of PGs are essential fatty acids with varying degrees of unsaturation, mainly arachidonic acid (C20:4) and γ-dihomolinolenic acid (C20:3), originating from the plasma membrane phospholipids. In response to various stimuli, these acids are cleaved from the membrane phospholipids by the enzyme phospholipase A2 and are then acted on by a complex group of enzymes given the generic name “prostaglandin synthetase”; the first step involves a cyclooxygenase, which transforms arachidonic acid into cyclic endoperoxides (PGG2 and PGH2); these unstable intermediates, with very short half-lives, are rapidly converted into PGE2, PGF2α, thromboxane A2 (TXA2), or prostacyclin (PGI2), depending upon the tissues considered (Fig. 1, review in Samuelsson et al. 1980).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akpan JO, Hurley MC, Pek S, Lands WEM (1979) The effects of prostaglandins on secretion of glucagon and insulin by the perfused rat pancreas. Can J Biochem 57: 540–547
Bergstrom S, Carlson LA, Weeks JR (1968) The prostaglandins: a family of biologically active lipids. Pharmacol Rev 20: 1–48
Bybee DE, Brodie TR, Georges LP, Fletcher JR, Diaz MJ, O’Brian JT (1978) Indomethacin induced augmentation of insulin and glucagon release ( Abstr ). Diabetes 27: 470
Flores AG A, Sharp GWP (1972) Endogenous prostaglandins and osmotic water flow in the toad bladder. Am J Physiol 223: 1392–1397
Frame CM, Ganuli S, Christensen R, Voina S, Madding C (1977) The role of endogenous prostaglandins in insulin and glucagon responses in the rat ( Abstr ). Diabetes 236: 397
Giugliano D, Torella R, Siniscalchi N, Improta L, D’Onofrio F (1978) The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Diabetologia 14: 359–362
Giugliano D, Torella R, Sgambato S, D’Onofrio F (1979) Effect of α-and β-adrenergic inhibition and somatostatin on plasma glucose, free fatty acids, insulin, glucagon, growth hormone responses to prostaglandin E1 in man. J Clin Endocrinol Metab 48: 302–308
Giugliano D, Luyckx AS, Lefebvre PJ ( 1980 a) Effect of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics. Diab Metab 6: 39–46
Giugliano D, Torella R, Sgambato S, D’Onofrio F (1980 b) Effect of furosemide on insulin and glucagon responses to arginine in normal subjects. Diabetologia 18: 293–296
Giugliano D, Torella R, D’Onofrio F (1981) Prostaglandins and the alpha-cell. Prostaglandins Med 6: 283–297
Goldblatt MW (1933) A depressor substance in seminal fluid. J Soc Chem India 52: 1056
Hamamdzic M, Malik KU (1977) Prostaglandins in adrenergic transmission of isolated perfused rat pancreas. Am J Physiol 232 (2): E201–E209
Hamberg M (1972) Inhibition of prostaglandins synthesis in man. Biochem Biophys Res Commun 49: 720–726
Hedqvist P (1970) Studies on the effect of prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in some animal tissues. Acta Physiol Scand 79: 1–40
Hedqvist P, Brundin T (1969) Inhibition by prostaglandin Ex of noradrenaline release and of effector responses to nerve stimulation in the cat spleen. Part I. Life Sci 8: 389–395
Hedqvist P, Stjârne L, Wennmalm A (1971) Facilitation of sympathetic neurotransmission in the cat spleen after inhibition of prostaglandin synthesis. Acta Physiol Scand 83: 430–432
Johnson DG, Thompson WJ, Williams RH (1974) Regulation of adenylylcyclase from isolated pancreatic islets by prostaglandins and guanosine 5′-triphosphate. Biochemistry 13: 1920–1924
Kantor HD, Hampton M (1978) Indomethacin in submicromolar concentrations inhibits cyclic AMP–dependent protein kinase. Nature 276: 841–842
Kelly KL, Laychock SG (1981) Prostaglandin synthesis and metabolism in isolated pancreatic islets of the rat. Prostaglandins 21: 759–769
Kuehl FA Jr (1974) Prostaglandins: cyclic nucleotides and cell function. Prostaglandins 5: 325–340
Kuo WN, Hodgkins DS, Kuo JF (1973) Adenylate cyclase in islets of Langerhans. Isolation of islets and regulation of adenylate cyclase activity by various hormones and agents. J Biol Chem 248: 2705–2711
Kurzrok R, Lieb CC (1930) Biochemical studies of human semen. Proc Soc Exp Biol Med 28: 268–282
Lefèbvre PJ, Luyckx AS (1978) Stimulation of gastric-glucagon release by prostaglandin E1 Prostaglandins Med 1: 419–420
Luyckx AS, Lefèbvre PJ (1978) Possible role of endogenous prostaglandins in glucagon secretion by isolated guinea-pig islets. Diabetologia 15: 411–416
Luyckx AS, Lefèbvre PJ (1979) Further studies on the role of prostaglandins in glucagon secretion. In: Abstracts of the fourth international prostaglandin conference, Washington DC, 27–31 May 1979, p 72
Luyckx AS, Lefèbvre PJ (1980 a) Further studies on the role of prostaglandins in glucagon secretion. In: Proceedings of the 2nd European symposium on hypoglycemia, Rome, January 1979. Academic Press, London New York, pp 47–56
Luyckx AS, Lefèbvre PJ (1980 b) Endogenous prostaglandins modulate glucagon secretion by isolated guinea-pig islets. Adv Prostaglandin Thromboxane Res 8: 1299–1302
Luyckx AS, Lefèbvre PJ ( 1980 c) Prostaglandins and glucagon release in vitro: effect of phospholipase A2, indomethacin, somatostatin and theophylline ( Abstr ). Diabetologia 19: 296
Luyckx AS, Lefèbvre PJ (1981) Prostaglandines et hormones pancréatiques. In: Journées annuelles de diabétologie de l’Hôtel Dieu. Flammarion, Paris, pp 27–41
Luyckx AS, Mendoza E, Lefèbvre PJ (1980) Furosemide intravenous infusion in normal man: electrolytic, metabolic and hormonal effects. Lack of changes in basal insulin and glucagon plasma levels. Arch Int Pharmacodyn 248: 305–313
Luyckx AS, Deliege M, Jardon-Jeghers CL, Lefèbvre PJ (1981 a) Insulin, prostaglandin E2 and glucagon release by human insuloma tissue incubated in vitro, influence of indomethacin. Diabete Me tab 7: 13–17
Luyckx AS, Gueurten D, Scheen A, Delporte JP, Lefèbvre P, Jaminet F (1981 b) Effect of indomethacin on the metabolic and hormonal response to a standardized breakfast in normal subjects. Acta Diabetol Lat 18: 259–266
Luyckx AS, Mendoza E, Lefèbvre PJ (1981 c) Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics-Major role of residual B-cell function in conditionning the magnitude of the blood glucose rise after intravenous arginine. Diabetologia 21: 376–382
Matsuyama T, Horie H, Namba M, Nonaka K, Tarui S (1983) Glucose dependent stimulation by prostaglandin-D2 of glucagon and insulin in perfused rat pancreas. Life Sci 32: 979–982
McCardel B, McAdams MR, Pek SB (1981) Relationship of prostaglandin synthesis to the effects of norepinephrine on islet-hormone secretion (Abstr). Endocrinology 108 (Suppl 1) 144
Metz SA, Fujimoto WY, Robertson RP (1980) A role for prostaglandins as mediators of α-adrenergic inhibition of the acute insulin response to glucose. Prostaglandin Thromboxane Res 8: 1291–1294
Micossi P, Pontiroli A, Baron SH, Tamayo RC, Lengel F, Bevilacqua M, Raggi U, Rorbiato G, Foa PP (1978) Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes 27: 1196–1204
Ojeda SR, Naor Z, Negro-Vilar A (1979) The role of prostaglandins in the control of gonadotropin and prolactin secretion. Prostaglandins Med 5: 249–275
Pace-Asciak C, Cole S (1975) Inhibitors of prostaglandin catabolism. I. Differential sensitivity of 9-sPGDH, 13-PGR and 15-PGDH to low concentrations of indomethacin. Experientia 31: 143–147
Pek S, Tai TY, Crowther R, Fajans SS (1976) Glucagon release precedes insulin release in response to common secretagogues. Diabetes 25: 764–770
Pek S, Tai TY, Elster A (1978) Stimulatory effects of prostaglandins E-1, E-2 and F-2-alpha on glucagon and insulin release in vitro. Diabetes 27: 801–809
Pek S, Lands EM, Akpan J, Hurley M (1980) Effect of prostaglandins H2, D2,I2 and thromboxane on in vitro secretion of glucagon and insulin. Adv Prostaglandin Thromboxane Res 8: 1295–1298
Prince RL, Larkins RG, Alford FP (1981) The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects. Metabolism 30: 293–298
Sacca L, Perez G (1976) Influence of prostaglandins on plasma glucagon levels in the rat. Metabolism 25: 127–130
Samuelsson B, Ramwell P, Paoletti R, (eds) (1980) Adv Prostaglandin Thromboxane Res 6 Schusdziarra V, Rouiller D, Jaffe BM, Harris V, Unger RH (1980) Effect of endogenous and endogenous prostaglandin E upon gastric endocrine function in dogs. Endocrinology 106: 1620–1627
Schusdziarra V, Rouiller D, Harris V, Wasada T, Unger RH (1981) Effect of prostaglandin E2 upon release of pancreatic somatostatin-like immunoreactivity. Life Sei 28: 2099–2102
Silver MJ, Smith JB (1975) Prostaglandins as intracellular messengers. Life Sei 16: 1635–1648
Simon LS, Mills JA (1980) Nonsteroidal antiinflammatory drugs. N Engl J Med 302: 1179–1185
Torella R, Giugliano D, Siniscalchio N, Sgambato S, D’Onofrio F (1979 a) Influence of acetylsalicylic acid on plasma glucose, insulin, glucagon and growth hormone levels following tolbutamide stimulation in man. Metabolism 28: 887–889
Torella R, Siniscalchio N, Improta L (1979b) The influence of acetylsalicylic acid on insulin, glucagon and growth hormone plasma levels following glucose and arginine in man. Farmaco 34: 131–137
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirinlike drugs. Nature New Biol 231: 232–235
Vierhapper H, Bratusch-Marrain P, Waldhausl W (1980) Unchanged arginine-induced stimulation of insulin, glucagon, growth hormone and prolactin after pretreatment with indomethacin in normal man. J Clin Endocrinol Metab 50: 1131–1134
von Euler US (1934) Zur Kenntnis der pharmakologischen Wirkungen von Nativsekreten und Extrakten männlicher accessorischer Geschlechtsdrüsen. Arch Exp Pathol Pharmakol 175: 78–84
Weir GC, Knowlton SC, Martin DB (1975) Nucleotide and nucleoside stimulation of glucagon secretion. Endocrinology 97: 932–936
Weiss B, Hait WN (1977) Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents. Annu Rev Pharmacol Toxicol 17: 441–477
Wollheim CB, Blondel B, Renold AE, Sharp GW (1976) Stimulatory and inhibitory effects of cyclic AMP on pancreatic glucagon release from monolayer cultures and the controlling role of calcium. Diabetologia 12: 269–277
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Luyckx, A.S., Lefebvre, P.J. (1983). Prostaglandins and Glucagon Secretion. In: Lefebvre, P.J. (eds) Glucagon II. Handbook of Experimental Pharmacology, vol 66 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69019-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-69019-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69021-1
Online ISBN: 978-3-642-69019-8
eBook Packages: Springer Book Archive